Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M407Revenue $M105Net Margin (%)16.0Altman Z-Score7.7
Enterprise Value $M401EPS $1.2Operating Margin %17.0Piotroski F-Score6
P/E(ttm)14.1Beneish M-Score--Pre-tax Margin (%)17.0Higher ROA y-yY
Price/Book0.510-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %-10.7Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %33.3ROA % (ttm)7.0Higher Current Ratio y-yN
Dividend Yield %1.3PEG--ROE % (ttm)8.6Less Shares Outstanding y-yY
Payout Ratio %30.0Shares Outstanding M23.6ROIC % (ttm)9.1Gross Margin Increase y-yN

Gurus Latest Trades with TRIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TRIBJohn Keeley 2011-09-30 Sold Out -0.0026%$9.25 - $10.83
($10.16)
$ 17.2570%Sold Out0
TRIBJohn Keeley 2011-03-31 Add$8.3 - $9.88
($8.91)
$ 17.2594%Add 53.33%16,100
TRIBJohn Keeley 2010-12-31 Reduce$6.3 - $8.9
($7.74)
$ 17.25123%Reduce 34.38%10,500
TRIBJohn Keeley 2010-06-30 Add$5.49 - $6.49
($6.08)
$ 17.25184%Add 45.45%16,000
TRIBJohn Keeley 2010-03-31 Buy $3.84 - $5.74
($4.54)
$ 17.25280%New holding11,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TRIB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


TRIB: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TRIB:

    News about TRIB:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Edited Transcript of TRIB earnings conference call or presentation 28-Jul-15 3:00pm GMT Jul 29 2015
    Trinity Biotech to Announce Q2 2015 Financial Results Jul 28 2015
    Trinity Biotech Announces Quarter 2 Financial Results Enrolment for the Meritas Troponin ACS Study... Jul 28 2015
    Q2 2015 Trinity Biotech PLC Earnings Release - Time Not Supplied Jul 28 2015
    Trinity Biotech Announces Q1 2015 Financial Results Jul 23 2015
    Trinity Biotech to Announce Q2 2015 Financial Results Jul 17 2015
    Trinity Biotech plc to Announce Second Quarter Fiscal Year 2015 Financial Results Jul 17 2015
    Trinity Biotech Announces Q1 2015 Financial Results Apr 30 2015
    Trinity Biotech to Announce Q1 2015 Financial Results Apr 23 2015
    Trinity Biotech Closes Offering of $115m of 4% Exchangeable Senior Notes due 2045 Apr 09 2015
    Trinity Biotech (TRIB) in Focus: Stock Tumbles 9.4% - Tale of the Tape Apr 06 2015
    Trinity Biotech plc Prices Offering of $100 Million of 4.00% Exchangeable Senior Notes due 2045 Apr 02 2015
    Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due... Apr 01 2015
    TRINITY BIOTECH PLC Financials Mar 28 2015
    Trinity Biotech Announces Q4 and FY 2014 Financial Results Mar 03 2015
    Trinity Biotech to Announce Q4 and FY 2014 Financial Results Feb 25 2015
    Trinity Biotech Announces Recommencement of US Clinical Trials for Troponin I Product Feb 23 2015
    Trinity Biotech Announces CLIA waiver of Rapid Syphilis Test Dec 16 2014
    Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% Oct 24 2014
    Trinity Biotech Announces Q3 2014 Financial Results Oct 23 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK